Filing Flows › CapsoVision (CV) › R&D spending
CapsoVision (CV) R&D spending by quarter
CapsoVision's R&D spending was $5.3M in Q2 2026 (second quarter 2026), +20% from Q1 2026. Over the last 5 quarters it ranged from $3.4M (Q2 2025) to $6.1M (Q3 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $5.3M | +20% | +57% |
| Q1 2026 | $4.4M | -22% | — |
| Q4 2025 | $5.7M | -6% | — |
| Q3 2025 | $6.1M | +80% | — |
| Q2 2025 | $3.4M | — | — |
Q2 2026 at a glance
CapsoVision, Q2 2026: revenue $3.6M (+10% year over year), operating margin -208.1%, net loss $7.5M, operating cash flow −$8.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is CapsoVision's R&D spending?
CapsoVision's R&D spending was $5.3M in Q2 2026 (second quarter 2026), +20% from Q1 2026.
How has CapsoVision's R&D spending changed?
Over the last 5 quarters it ranged from $3.4M (Q2 2025) to $6.1M (Q3 2025).